Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05481931

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Sponsor: Evolus, Inc.

View on ClinicalTrials.gov

Summary

Non-interventional PASS of NUCEIVA for the treatment of moderate-to-severe glabellar lines to provide additional characterisation of the long-term safety of NUCEIVA in the real-world clinical practice setting.

Official title: Non-Interventional Post-Authorisation Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Key Details

Gender

All

Age Range

18 Years - 64 Years

Study Type

OBSERVATIONAL

Enrollment

756

Start Date

2023-03-15

Completion Date

2026-01

Last Updated

2025-08-05

Healthy Volunteers

Yes

Interventions

DRUG

prabotulinumtoxinA

Botulinum toxin Type A powder for solution for injection

Locations (1)

Cologne Dermatology

Cologne, Germany